D-PENICILLAMINE-INDUCED AND QUINIDINE-INDUCED ANTINUCLEAR ANTIBODIES IN A.SW (H-2(S)) MICE - SIMILARITIES WITH AUTOANTIBODIES IN SPONTANEOUS AND HEAVY METAL-INDUCED AUTOIMMUNITY
M. Monestier et al., D-PENICILLAMINE-INDUCED AND QUINIDINE-INDUCED ANTINUCLEAR ANTIBODIES IN A.SW (H-2(S)) MICE - SIMILARITIES WITH AUTOANTIBODIES IN SPONTANEOUS AND HEAVY METAL-INDUCED AUTOIMMUNITY, European Journal of Immunology, 24(3), 1994, pp. 723-730
Ten percent of human lupus syndromes occur in patients as a result of
treatment with certain medications. H-2(s) mice can produce autoantibo
dies following treatment with various drugs or heavy metals and they a
re a potential animal model of drug-induced lupus. We have examined ni
ne anti-chromatin monoclonal antibodies (mAb) from A.SW mice that had
been treated with either D-penicillamine or quinidine, two lupus-induc
ing drugs in humans. These mAb are specific either for DNA or histone-
DNA complexes corresponding to nucleosomes or subnucleosome particles.
Only one mAb reacts with an unknown chromatin antigen. The V region s
equences of six of these mAb were studied and are notable by several f
eatures. As previously observed in spontaneous autoantibodies to DNA o
r histone-DNA complexes, arginine or asparagine residues are found at
critical locations throughout the V regions. Many of these residues, p
otentially important for binding to DNA or DNA-histone complexes, resu
lt either from somatic mutations or atypical V-H-D-J(H) rearrangements
. Another significant characteristic is that the V-H genes of several
D-penicillamine- or quinidine-induced mAb are most similar to those of
anti-nucleolar mAb obtained from mercury-injected A.SW mice. The impl
ications of these findings for the pathogenesis of spontaneous or indu
ced autoimmunity are discussed.